NLRP3 and CINCA syndrome: In 2002, Feldmann and colleagues identified NLRP3 pathogenic variants associated to CINCA/NOMID; none of these pathogenic variants were previously described in FCAS and MWS family, and the majority of probands presented de novo mutations (81).